These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 8782499
1. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG. N Engl J Med; 1996 Sep 26; 335(13):924-30. PubMed ID: 8782499 [Abstract] [Full Text] [Related]
2. New diagnostic tests for prion diseases. Collinge J. N Engl J Med; 1996 Sep 26; 335(13):963-5. PubMed ID: 8782506 [No Abstract] [Full Text] [Related]
3. The assay development of a molecular marker for transmissible spongiform encephalopathies. Lee KH, Harrington MG. Electrophoresis; 1997 Sep 26; 18(3-4):502-6. PubMed ID: 9150931 [Abstract] [Full Text] [Related]
5. The 14-3-3 brain protein and transmissible spongiform encephalopathy. Zerr I, Bodemer M, Weber T. N Engl J Med; 1997 Mar 20; 336(12):874; author reply 874-5. PubMed ID: 9072685 [No Abstract] [Full Text] [Related]
8. A novel binding assay for detection of 14-3-3 protein in cerebrospinal fluid from Creutzfeldt-Jakob patients. Leuck J, Peoch K, Laplanche JL, Grabar E, Müller WE, Schröder HC. Cell Mol Biol (Noisy-le-grand); 2000 Nov 20; 46(7):1291-6. PubMed ID: 11075958 [Abstract] [Full Text] [Related]
9. An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients. Kenney K, Brechtel C, Takahashi H, Kurohara K, Anderson P, Gibbs CJ. Ann Neurol; 2000 Sep 20; 48(3):395-8. PubMed ID: 10976650 [Abstract] [Full Text] [Related]
10. [Clinical algorithm for cerebrospinal fluid test of 14-3-3 protein in diagnosis of Creutzfeldt-Jacob disease]. Lemstra AW, van Meegen M, Baas F, van Gool WA. Ned Tijdschr Geneeskd; 2001 Jul 28; 145(30):1467-71. PubMed ID: 11503317 [Abstract] [Full Text] [Related]
12. The 14-3-3 brain protein and transmissible spongiform encephalopathy. Moussavian M, Potolicchio S, Jones R. N Engl J Med; 1997 Mar 20; 336(12):873-4; author reply 874-5. PubMed ID: 9072684 [No Abstract] [Full Text] [Related]
14. [Diagnostic usefulness of the determination of protein 14-3-3 in cerebrospinal fluid in Creutzfeld-Jakob disease]. Sáiz A, Marín C, Tolosa E, Graus F. Neurologia; 1998 Mar 20; 13(7):324-8. PubMed ID: 9810794 [Abstract] [Full Text] [Related]
15. Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease. Brechlin P, Jahn O, Steinacker P, Cepek L, Kratzin H, Lehnert S, Jesse S, Mollenhauer B, Kretzschmar HA, Wiltfang J, Otto M. Proteomics; 2008 Oct 20; 8(20):4357-66. PubMed ID: 18814332 [Abstract] [Full Text] [Related]
19. Apolipoprotein E and other cerebrospinal fluid proteins differentiate ante mortem variant Creutzfeldt-Jakob disease from ante mortem sporadic Creutzfeldt-Jakob disease. Choe LH, Green A, Knight RS, Thompson EJ, Lee KH. Electrophoresis; 2002 Jul 20; 23(14):2242-6. PubMed ID: 12210228 [Abstract] [Full Text] [Related]